Free Trial
OTCMKTS:CDBT

China Dasheng Biotechnology (CDBT) Stock Price, News & Analysis

$0.06 0.00 (0.00%)
As of 10/2/2026

About China Dasheng Biotechnology Stock (OTCMKTS:CDBT)

Advanced

Key Stats

Today's Range
$0.06
▼
$0.06
50-Day Range
$0.06
▼
$0.06
52-Week Range
$0.00
▼
$0.15
Volume
N/A
Average Volume
12,561 shs
Market Capitalization
$2.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, China Dasheng Biotechnology Company engages in residential and commercial real estate investment. The company was formerly known as Max Nutrition, Inc. and changed its name to China Dasheng Biotechnology Company in March 2008. China Dasheng Biotechnology Company was founded in 2004 and is based in Lanzhou, China.

Receive CDBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Dasheng Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CDBT Stock News Headlines

CDBT'S Transport Operations Expand
Inside the Options Play With a High Historical Win Rate
Ian Cooper's newest strategy targets triple-digit returns in just 9 days. It doesn't work every time, but a 73% win rate and 2,671% return on capital stand on their own. Ian is breaking down the full strategy and offering his newest report at no charge.tc pixel
CDBT to acquire Cycclone Magnetic Engines
China Dasheng Biotechnology Company (CDBT)
China Dasheng Biotechnology Co.
See More Headlines

CDBT Stock Analysis - Frequently Asked Questions

China Dasheng Biotechnology's stock was trading at $0.0390 at the start of the year. Since then, CDBT stock has increased by 53.8% and is now trading at $0.06.

Shares of CDBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that China Dasheng Biotechnology investors own include Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Global X Cloud Computing ETF (CLOU), VelocityShares 1x Long VSTOXX Futures ETN (EVIX) and First Trust United Kingdom AlphaDEX Fund (FKU).

Company Calendar

Today
10/08/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Materials
Industry
Drug stores & proprietary stores
Sub-Industry
Retail
Current Symbol
OTCMKTS:CDBT
CIK
N/A
Web
N/A
Employees
689
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
40,976,000
Free Float
N/A
Market Cap
$2.46 million
Optionable
Not Optionable
Beta
2.25
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (OTCMKTS:CDBT) was last updated on 10/8/2026 by MarketBeat.com Staff.
From Our Partners